BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
7 hedge funds and large institutions have $15.1K invested in BriaCell Therapeutics Corp Warrant in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
75% more funds holding
Funds holding: 4 → 7 (+3)
3.84% more ownership
Funds ownership: 1.26% → 5.11% (+3.8%)
88% less capital invested
Capital invested by funds: $129K → $15.1K (-$113K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$4.27K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.25K |
| 3 |
CS
Clear Street
New York
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$48.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$516 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RAM
1
Redmond Asset Management
Henrico,
Virginia
| $7.65K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $3.14K | +$4.27K | +30,838 | New |
|
|
AC
3
Armistice Capital
New York
| $2.55K | -$48.5K | -350,000 | -93% |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.44K | +$2.25K | +16,246 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $274 | -$516 | -3,724 | -58% |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $72 | – | – | – |
|
|
CS
7
Clear Street
New York
| $10 | +$14 | +100 | New |
|
BCTXW Hedge Fund Activity: Q1 2025 in Review
7 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q1 2025, worth a combined $15.1K — down 88% from $129K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BCTXW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $4.27K. The largest seller was Armistice Capital, cutting an estimated $48.5K.
- 7 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q1 2025, up from 4 in Q4 2024.
- Funds reported $15.1K of BriaCell Therapeutics Corp Warrant stock for Q1 2025, down 88% quarter-over-quarter.
- 3 funds opened new BriaCell Therapeutics Corp Warrant positions in Q1 2025 and 0 closed out, a net change of +3 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q1 2025 was Two Sigma Securities, an estimated $4.27K added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q1 2025 was Armistice Capital, an estimated $48.5K sold.
Based on aggregated 13F filings for Q1 2025.